RECURRENT SOLID TUMOR
Clinical trials for RECURRENT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new RECURRENT SOLID TUMOR trials appear
Sign up with your email to follow new studies for RECURRENT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive nanoparticles target Tough-to-Treat cancers in new trial
Disease control Recruiting nowThis is a first-in-human study testing a new experimental drug called 177Lu-SN201 in adults with advanced solid tumors that have progressed despite standard treatments. The drug is a radioactive nanoparticle designed to accumulate in tumors. The main goals are to find a safe and …
Matched conditions: RECURRENT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Spago Nanomedical AB • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New 'Smart Bomb' drug seeks to target multiple advanced cancers
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of a new investigational drug called LY4052031 for people with advanced or metastatic solid tumors. The drug is designed to target a specific protein found on many cancer cells, delivering its medicine dire…
Matched conditions: RECURRENT SOLID TUMOR
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New cancer drug enters human testing for multiple advanced tumors
Disease control Recruiting nowThis is the first human study of an experimental cancer drug called LY4101174. Researchers want to find a safe dose and see if it can help control advanced cancers that have spread or returned after other treatments. The study will enroll about 490 people with various solid tumor…
Matched conditions: RECURRENT SOLID TUMOR
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
New hope for kids with tough cancers: trial tests Double-Team drug strategy
Disease control Recruiting nowThis study is testing two different drug combinations to find safe doses and see if they can help control cancer in children and young adults whose solid tumors have come back or haven't responded to treatment. In the first part, participants will be assigned to receive either On…
Matched conditions: RECURRENT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC